180 Life Sciences Corp. (ATNF) Soars 52.99% on $156M Funding Round

180 Life Sciences Corp. (NASDAQ: ATNF) has seen a remarkable surge in its stock price, rising by 52.99% in pre-market trading on August 12, 2025. This significant increase comes on the heels of several strategic financial moves by the company.

180 Life Sciences recently closed a private offering of approximately $156 million in senior secured convertible notes due 2028. This substantial capital infusion is aimed at expanding the company's Ethereum treasury strategy, which has been a key focus for the company in recent months. The funds raised will be used to bolster the company's financial position and support its ongoing initiatives in the Ethereum ecosystem.

The successful completion of this offering has been met with enthusiasm from investors, who see it as a strategic move to enhance the company's capabilities in the rapidly evolving blockchain and cryptocurrency landscape. The convertible notes provide the company with the flexibility to convert the debt into equity in the future, offering a potential upside for investors while providing the company with the necessary capital to execute its plans.

This financial maneuver is part of a broader trend of institutional capital flowing into Ethereum, as more companies recognize the potential of blockchain technology and its applications. The company's proactive approach to securing funding and expanding its Ethereum holdings has positioned it as a leader in the industry, attracting the attention of both investors and industry observers.